| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c24162 _d24162 |
||
| 001 | BD-DhNSU-24162 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403071136.0 | ||
| 008 | 190403s2011 enka|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0748409602 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRS201 _b.P8Z46 2011 |
| 100 | 1 | _aZeng, Xian Ming | |
| 245 | 0 | 0 |
_aParticulate interactions in dry powder formulations for inhalation / _cXian Ming Zeng, Gary P. Martin and Christopher Marriott |
| 260 |
_aLondon : _bInforma Healthcare, _cc2011. |
||
| 300 |
_aviii, 255 p. : _bill. ; _c26 cm. |
||
| 650 | 0 | _aPowders | |
| 650 | 4 | _aPharmacy | |
| 650 | 4 | _aAerosol therapy | |
| 700 | 1 | _aMartin, Gary P. | |
| 700 | 1 | _aMarriott, Christopher | |
| 942 |
_2lcc _cBK |
||